Retraction: Identification of VLDL as a Biomarker for Prewarning of Androgenic Alopecia
January 2026
in “
Skin Research and Technology
”
TLDR The study's findings on VLDL as a biomarker for hair loss are unreliable.
The article "Identification of VLDL as a Biomarker for Prewarning of Androgenic Alopecia" has been retracted due to an insufficient peer review process that failed to meet the journal's standards. The study's findings are not considered scientifically sound because it lacks the necessary biological rationale to support the use of Mendelian Randomization. Consequently, the editorial team cannot confirm the validity of the methods or the reliability of the conclusions. The authors have been informed of the retraction but disagree with the decision.
